WANBURY
|
The Current P/E Ratio of WANBURY is 30.10.
Share Price | ₹279.3 | Jul 01,2025 |
Market Cap | ₹918.9 Cr | |
Earnings-TTM | ₹30.5 Cr | TTM-Consolidated Results |
Price/Earnings | 30.10x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of WANBURY
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹918.9 Cr] as on Jul 01,2025
(/) Earnings [ ₹30.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 30.10x ]
Thus, for WANBURY , the investors are currently willing to pay 30.10 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of WANBURY !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of WANBURY over the last five years.
Historical PE (Price/Earnings) ratio chart of WANBURY
PE Ratio Performance Analysis for WANBURY
- WANBURY 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.53x.
- WANBURY 's operated at median p/e ratio of 0.71x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WANBURY 's p/e ratio peaked in Mar2024 at 8.54x.
- WANBURY 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does WANBURY 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
WANBURY | 30.53 | 30.10 | 918.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 36.43 | 400,017.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 83.01 | 181,867.0 |
CIPLA LTD | 5,291.05 | 23.14 | 122,451.0 |
TORRENT PHARMACEUTICALS LTD | 1,911.00 | 60.50 | 115,620.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 18.69 | 106,572.0 |
MANKIND PHARMA LTD | 2,003.22 | 47.16 | 94,465.4 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 21.84 | 100,769.0 |
LUPIN LTD | 3,306.26 | 27.09 | 89,575.7 |
AUROBINDO PHARMA LTD | 3,515.26 | 18.71 | 65,775.8 |
ABBOTT INDIA LTD | 1,414.44 | 52.13 | 73,729.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs WANBURY 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.69x |
Max industry PE | 83.01x |
Median industry PE | 30.10x |
Average industry PE | 38.07x |
You may also like the below Video Courses